If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Merck (MRK) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!
Merck (MRK) - pharmaceutical giant's drugs are used in the treatment of cardiovascular ailments, hypertension, high cholesterol, inflammation, glaucoma, ulcers, hepatitis, and Parkinsons disease. Here are some of the familiar names. It offers Singulair for treating asthma, and relief of symptoms of allergic rhinitis; Cozaar/Hyzaar and Vasotec for the treatment of hypertension/heart failure; Fosamax and Fosamax Plus D for the treatment and prevention of osteoporosis; Zocor, an atherosclerosis product; Primaxin and Cancidas, anti-bacterial/anti-fungal products; Cosopt and Trusopt, the ophthalmological products; Proscar, an urology product for the treatment of symptomatic benign prostate enlargement; Maxalt, an acute migraine product; and Propecia for the treatment of male pattern hair loss. The company offers Varivax to prevent chickenpox; M-M-R II, for the treatment of measles, mumps, and rubella; ProQuad, a pediatric combination vaccine against measles, mumps, rubella, and varicella; Gardasil for the prevention of cervical cancer and genital warts; Pneumovax for the prevention of pneumococcal diseases; RotaTeq for the protection against rotavirus gastroenteritis in infants and children; and Zostavax, a vaccine for the prevention of shingles. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.
** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.
*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
The following dividend stocks are considered direct competitors of Merck (MRK):